![Thomas Smart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Smart
Directeur/Membre du Conseil chez
RIGImmune, Inc.
Profil
Thomas E.
Smart is the founder of Gravitas Therapeutics, Inc. Mr. Smart currently serves as Director at RIGImmune, Inc. and as Vice President-Business Development at XOMA (US) LLC.
Formerly, Mr. Smart was Co-Chairman & Chief Executive Officer at AnaptysBio, Inc. in 2011, Chief Executive Officer at Actym Therapeutics, Inc., Director at Acologix, Inc., Principal at Cell Genesys, Inc., Principal at Genetics Institute LLC, Principal at Pfizer Inc., Senior Vice President-Corporate Development at GenVec, Inc., and Chief Business Officer at XOMA Royalty Corp.
Mr. Smart completed undergraduate studies at Cornell University and earned an MBA from The University of Chicago Booth School of Business.
Postes actifs de Thomas Smart
| Sociétés | Poste | Début |
|---|---|---|
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | - |
RIGImmune, Inc.
 RIGImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune modulating therapies for diseases caused by RNA viruses | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Smart
| Sociétés | Poste | Fin |
|---|---|---|
Gravitas Therapeutics, Inc.
 Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Directeur Général | 01/10/2023 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Directeur Général | - |
| XOMA ROYALTY CORPORATION | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Formation de Thomas Smart
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Acologix, Inc.
 Acologix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
RIGImmune, Inc.
RIGImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune modulating therapies for diseases caused by RNA viruses | Health Technology |
Gravitas Therapeutics, Inc.
Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical-stage antifungal for treatment of aspergillus mold infections | Commercial Services |
